239 related articles for article (PubMed ID: 18606464)
1. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.
Rees CR; Costin JM; Fink RC; McMichael M; Fontaine KA; Isern S; Michael SF
Antiviral Res; 2008 Nov; 80(2):135-42. PubMed ID: 18606464
[TBL] [Abstract][Full Text] [Related]
2. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell.
Talarico LB; Pujol CA; Zibetti RG; FarÃa PC; Noseda MD; Duarte ME; Damonte EB
Antiviral Res; 2005 Jun; 66(2-3):103-10. PubMed ID: 15911027
[TBL] [Abstract][Full Text] [Related]
3. Interference in dengue virus adsorption and uncoating by carrageenans.
Talarico LB; Damonte EB
Virology; 2007 Jul; 363(2):473-85. PubMed ID: 17337028
[TBL] [Abstract][Full Text] [Related]
4. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
5. 3-O-sulfated glucuronide derivative as a potential anti-dengue virus agent.
Hidari KI; Ikeda K; Watanabe I; Abe T; Sando A; Itoh Y; Tokiwa H; Morita K; Suzuki T
Biochem Biophys Res Commun; 2012 Aug; 424(3):573-8. PubMed ID: 22776202
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection.
Alen MM; Kaptein SJ; De Burghgraeve T; Balzarini J; Neyts J; Schols D
Virology; 2009 Apr; 387(1):67-75. PubMed ID: 19264337
[TBL] [Abstract][Full Text] [Related]
7. An algal-derived DL-galactan hybrid is an efficient preventing agent for in vitro dengue virus infection.
Talarico LB; Duarte ME; Zibetti RG; Noseda MD; Damonte EB
Planta Med; 2007 Nov; 73(14):1464-8. PubMed ID: 17948168
[TBL] [Abstract][Full Text] [Related]
8. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
9. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN
Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein.
Kato D; Era S; Watanabe I; Arihara M; Sugiura N; Kimata K; Suzuki Y; Morita K; Hidari KI; Suzuki T
Antiviral Res; 2010 Nov; 88(2):236-43. PubMed ID: 20851716
[TBL] [Abstract][Full Text] [Related]
11. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
Kuo YT; Liu CH; Li JW; Lin CJ; Jassey A; Wu HN; Perng GC; Yen MH; Lin LT
Sci Rep; 2020 Oct; 10(1):16378. PubMed ID: 33009425
[TBL] [Abstract][Full Text] [Related]
12. A small molecule fusion inhibitor of dengue virus.
Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
[TBL] [Abstract][Full Text] [Related]
13. Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells.
Acosta EG; Piccini LE; Talarico LB; Castilla V; Damonte EB
Virus Res; 2014 May; 184():39-43. PubMed ID: 24583230
[TBL] [Abstract][Full Text] [Related]
14. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
[TBL] [Abstract][Full Text] [Related]
15. Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus.
Laosutthipong C; Kanthong N; Flegel TW
Antiviral Res; 2013 Jun; 98(3):449-56. PubMed ID: 23603496
[TBL] [Abstract][Full Text] [Related]
16. In vitro analysis of synthetic peptides in blocking the entry of dengue virus.
John AM; Jittmittraphap A; Chattanadee S; Alwin Prem Anand A; Shenbagarathai R; Leaungwutiwong P
Virus Res; 2019 Jan; 260():142-150. PubMed ID: 30508603
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dengue virus polymerase by blocking of the RNA tunnel.
Niyomrattanakit P; Chen YL; Dong H; Yin Z; Qing M; Glickman JF; Lin K; Mueller D; Voshol H; Lim JY; Nilar S; Keller TH; Shi PY
J Virol; 2010 Jun; 84(11):5678-86. PubMed ID: 20237086
[TBL] [Abstract][Full Text] [Related]
18. A high-throughput assay using dengue-1 virus-like particles for drug discovery.
Qing M; Liu W; Yuan Z; Gu F; Shi PY
Antiviral Res; 2010 May; 86(2):163-71. PubMed ID: 20153777
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses.
Lee E; Pavy M; Young N; Freeman C; Lobigs M
Antiviral Res; 2006 Jan; 69(1):31-8. PubMed ID: 16309754
[TBL] [Abstract][Full Text] [Related]
20. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
